Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lymphocytes

被引:45
作者
Fonseca, AM
Porto, G
Uchida, K
Arosa, FA
机构
[1] Univ Porto, Inst Mol & Cell Biol, Lab Mol Immunol, P-4150 Oporto, Portugal
[2] Santo Antonio Gen Hosp, Dept Hematol, Oporto, Portugal
[3] Nagoya Univ, Grad Sch BioAgr Sci, Lab Food & Biodynam, Nagoya, Aichi, Japan
关键词
D O I
10.1182/blood.V97.10.3152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Red blood cells (RBCs) are known to perform one prominent function: to carry and deliver oxygen to the tissues. Earlier studies, however, suggested a role for RBCs in potentiating T-cell proliferation in vitro. Here it is shown that the presence of RBCs in cultures of stimulated human peripheral blood lymphocytes strengthens T-cell proliferation and survival. Analysis of phosphatidylserine, externalization and DNA fragmentation showed that RBCs inhibit T-cell apoptosis. This inhibition correlated with a reduction in CD71 but not CD95 expression. RBCs enhanced T-cell proliferation and survival upon activation with phytohemagglutinin and with OKT3 antibodies. Studies aimed at characterizing the cellular and molecular basis of the protection afforded to T cells by RBCs showed that (1) optimal protection required intact RBCs and red cell/T-cell contact but not monocytes; (2) RBCs markedly reduced the level of intracellular reactive oxygen species; and (3) RBCs inhibited the formation of protein-bound acrolein, a peroxidation adduct in biologic systems. Overall, these data indicate that human RBCs protect T cells from activation-induced cell death, at least in part by reducing the pro-oxidant state, and suggest a role for RBCs as conceivable modulators of T-cell homeostasis. (Blood. 2001;97: 3152-3160) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:3152 / 3160
页数:9
相关论文
共 81 条
[1]   ERYTHROCYTE CATALASE - A SOMATIC OXIDANT DEFENSE [J].
AGAR, NS ;
SADRZADEH, SMH ;
HALLAWAY, PE ;
EATON, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (01) :319-321
[2]   Red blood cells inhibit apoptosis of human neutrophils [J].
Aoshiba, K ;
Nakajima, Y ;
Yasui, S ;
Tamaoki, J ;
Nagai, A .
BLOOD, 1999, 93 (11) :4006-4010
[3]   Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules [J].
Arosa, FA ;
de Jesus, O ;
Porto, G ;
Carmo, AM ;
de Sousa, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :16917-16922
[4]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[5]   Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death [J].
Ayroldi, E ;
Zollo, O ;
Cannarile, L ;
D' Adamio, FD ;
Grohmann, U ;
Delfino, DV ;
Riccardi, C .
BLOOD, 1998, 92 (11) :4212-4219
[6]  
BASS DA, 1983, J IMMUNOL, V130, P1910
[7]  
Brittenham G., 1994, Iron Metabolism in Health and Disease, P31
[8]   ERYTHROCYTES DECREASE MYOCARDIAL HYDROGEN-PEROXIDE LEVELS AND REPERFUSION INJURY [J].
BROWN, JM ;
GROSSO, MA ;
TERADA, LS ;
BEEHLER, CJ ;
TOTH, KM ;
WHITMAN, GJ ;
HARKEN, AH ;
REPINE, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02) :H584-H588
[9]  
Carmo AM, 1999, J IMMUNOL, V163, P4238
[10]   Iron compounds after erythrophagocytosis: Chemical characterization and immunomodulatory effects [J].
Costa, LMG ;
Moura, EMF ;
Moura, JJG ;
de Sousa, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (01) :159-165